Trial intelligence / Profile preview

Zegerid vs Prilosec OTC in Healthy Volunteers

NCT01077076Phase 3Completed

Sponsor
Bayer
Start
Dec 2008
Primary completion
Mar 2009
Modality
Small Molecules
01

Overview

A Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Bayer. Started Dec 2008; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT01077076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01077076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call